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Abstract 
Ochola, D. O., Sharif, R., Bedford, J. S., Keefe, T. J., Kato, T. A., Fallgren C. M., Demant, P. 
and Weil, M. M. 
 
Persistence of -H2AX Foci in Irradiated Bronchial Cells Correlates with Susceptibility to 
Radiation Associated Lung Cancer in Mice 
 
The risk of developing radiation-induced lung cancer differs between different strains of mice, 
but the underlying cause of the strain differences is unknown.  Strains of mice also differ in their 
ability to efficiently repair DNA double strand breaks resulting from radiation exposure.  We 
phenotyped mouse strains from the CcS/Dem recombinant congenic strain set for their efficacy 
in repairing DNA double strand breaks during protracted radiation exposures.  We monitored 
persistent -H2AX radiation induced foci (RIF) 24 hours after exposure to chronic gamma-rays 
as a surrogate marker for repair deficiency in bronchial epithelial cells for 17 of the CcS/Dem 
strains and the BALB/cHeN founder strain. We observed a very strong correlation R2 = 79.18%, 
P < 0.001) between the level of persistent RIF and radiogenic lung cancer percent incidence 
measured in the same strains. Interestingly, spontaneous levels of foci in non-irradiated strains 
also showed good correlation with lung cancer incidence (R2=32.74%, P =0.013). These results 
suggest that genetic differences in DNA repair capacity largely account for differing 
susceptibilities to radiation-induced lung cancer among CcS/Dem mouse strains and that high 
levels of spontaneous DNA damage is also a relatively good marker of cancer predisposition.  In 
a smaller pilot study, we found that the repair capacity measured in peripheral blood leucocytes 
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also correlated well with radiogenic lung cancer susceptibility, raising the possibility that such 
phenotyping assay could be used to detect radiogenic lung cancer susceptibility in humans.   
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INTRODUCTION 
 
Radiation exposure carries with it an increased risk for lung cancer.  This increased risk has been 
observed in atomic bomb survivors (1) and in cohorts with medical (2) (NCRP No 170, section 
9.4), occupational, and environmental radiation exposures (3).  Radiation-induced lung cancer 
remains a concern for diagnostic radiology and radiotherapy patients, and the risk of radiogenic 
lung cancer is a factor in limiting flight times for spaceflight crew members (4).  There is some 
evidence for genetic susceptibility to radiogenic lung cancer in humans (5, 6), but the relative 
contributions of the pathways through which naturally occurring genomic sequence variants are 
manifested (e.g., DNA repair, apoptosis, EGFR signaling) are unknown.   
 
Inbred mouse strains differ in their susceptibilities to radiogenic cancers, including lung cancer 
(7), and these strain differences in susceptibility are likely due to genetic differences between 
strains.  The CcS/Dem recombinant congenic strain set consists of 20 inbred strains (CcS1 
through CcS20) derived from the BALB/cHeA and STS/A founder strains (8, 9).  Each CcS/Dem 
strain is genetically distinct and has approximately 87.5 percent of its genome derived from the 
BALB/c founder and the remainder from STS/A.  The strains have been phenotyped for their 
incidences of radiation-induced lung cancers and hematopoietic malignancies, and vary 
considerably in their susceptibilities to both (9). 
 
Ionizing radiation induces DNA double strand breaks (DSB), and the misrepair of these lesions 
can contribute to carcinogenesis.  Individuals differ in their capacity to efficiently repair DNA 
DSB and there are also differences in repair efficiencies between mouse strains.  It has been 20 
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years since the discovery that the histone variant H2AX was specifically modified only at sites of 
DSBs (1), giving rise to immunofluorescent techniques and a quantitative surrogate marker for 
radiation-induced DSBs in eukaryotic cells (2). Capitalizing on such discovery, we previously 
introduced a sensitive assay reflecting the repair efficacy of radiation-induced DNA DSB based 
on evaluating the persistence of γ-H2AX foci in cells irradiated at low dose rate, the LDR γ-
H2AX assay (10).  In this latter work, we showed that the assay was able to identify individuals 
with hypersensitivity radiation induced G(1) arrest and cell killing later linked to DNA repair 
differences among clinically normal individuals (10).  Here, we phenotype the CcS/Dem strains 
for their DNA DSB break repair efficiencies using the same LDR -H2AX assay and compare 
the results to those previously obtained for their susceptibilities to radiogenic lung cancer as 
described in the original study (9). We find a strong correlation between the strain differences in 
susceptibility to radiation associated lung cancer and the persistence of -H2AX foci in irradiated 
bronchial epithelial cells.   The correlation extends to the baseline damage in un-irradiated 
bronchial epithelial cells for all strains as well as in leucocytes from irradiated animals from a 
smaller cohort conducted at Colorado State University.  Within the CcS/Dem strain set, 
genetically determined differences in DNA DSB repair account for most of the differences 
between strains in radiogenic lung cancer incidence.  This finding suggests that assays to predict 
individual susceptibility to radiation-induced lung cancers can be developed around the usage of 
both baseline levels of DNA damage and persistence of damage in irradiated samples. 
 
MATERIALS AND METHODS 
 
Mice   
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Female CcS/Dem and BALB/cHeA mice were assayed at 11 to 15 weeks of age.  All animal 
work followed American Association for Laboratory Animal Science policies and was approved 
by the Colorado State University Institutional Animal Care and Use Committee under protocol 
09-1582A. 
 
Irradiation   
Mice were irradiated with 137Cs -rays at a dose rate of 10 cGy/h for 24 h to a cumulative dose of 
2.4 Gy. During irradiation the mice were housed in ventilated 5x5x8 cm polystyrene boxes with 
a cube of Nutra-Gel (Bio Serv, Flemington, NJ) for food and hydration.  Sham-irradiated mice 
that served as controls were treated under similar conditions, but without the 137Cs source being 
exposed.  
 
Tissue collection 
Mice were euthanized immediately following irradiation and their lungs were perfused in situ.  
Fixed lung tissue was paraffin embedded and sectioned for H2AX foci detection by 
immunofluorescence.  For foci detection in peripheral blood mononuclear cells, heparinized 
blood was collected by cardiac puncture, and erythrocytes lysed with distilled water.  The 
leucocytes were then deposited onto slides, and fixed (detailed methods in Supplemental 
Methods). 
 
Immunofluorescence staining and quantitation of foci 
Paraffin embedded samples were de-waxed and re-hydrated by the standard method followed by 
antigen retrieval with sodium citrate and microwave (11). Leucocyte samples were treated with 
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sodium borohydride solution to reduce autofluorescence background signals (12).  Slides were 
stained by anti-gamma-H2AX antibody (Millipore) and Alexa Fluor 594 conjugated secondary 
antibody, and counter stained by DAPI. 
  
Extended focus images were obtained by Nikon E600 fluorescence motorized microscope with 
CoolSNAP HQ camera controlled by Optiscan stage system (Prior Photometrics, Tuscon, AZ) 
and MetaMorph Software (Molecular Devices, Sunnyvale, CA).  Visual counting was performed 
to quantify the foci number per cell.  Cells with diffuse H2AX staining suggestive of apoptosis 
were excluded from counted.  
 
Data analysis 
Summary statistics, which included the number of mice (n) per strain and the mean and standard 
deviation (StDev) of the foci counts weighted by the number of cells counted per mouse by 
observer 1 or observer 2 (102.2 ± 1.6 and 80.8 ± 39.4, respectively), were calculated using 
Release 17 of the statistical package Minitab (State College, PA).  The Pearson correlation 
coefficient was calculated for the relationship between DNA repair efficiency (as measured by 
the mean number of foci per nucleus) and the incidence of radiation associated lung tumors using 
GraphPad Prism software (San Diego, CA).   
 
RESULTS 
 
It was previously shown that CcS/Dem strains and their BALB/cHeA and STS/A founder strains 
differ in their susceptibilities to radiogenic lung cancer, lymphomas, and leukemias (9).  In that 
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study, mice of both sexes were irradiated to the whole body with four 1.5 Gy weekly fractions 
and monitored until they became moribund or reached 450 days of age.  The incidences of lung 
cancer in the strains, originally reported in Szymanska et al (9), are provided in Table 1.  
 
We considered the possibility that strain differences in the efficacy of DNA DSB repair might 
account for the strain differences in radiogenic lung cancer susceptibility.  To quantify DNA 
DSB repair efficacy we used the low dose rate -H2AX assay we have described previously (10, 
13, 14).  This assay measures differences in the DNA DSB repair capacities of cells by 
irradiating them at low dose rate over 24 hours, a condition which results in the greater 
accumulation of DSB in those cells that have less efficient DNA DSB repair. The DNA DSB 
remaining in the cells immediately following the 24 hour exposure are quantified as -H2AX 
foci.  Presumably, greater numbers of persistent foci indicate less efficient repair.  Our previous 
work has been focusing on irradiating cells in vitro with this assay.  However, since the target 
cells for radiogenic lung cancer are thought to be bronchial epithelial cells, in this work we 
irradiated live mice from 17 of the CcS/Dem strains and the BALB/cHeN founder strain at low 
dose rate for 24 hours, instead.  Immediately following irradiation, the mice were euthanized, 
their lungs perfused with fixative to stop further DNA damage-related processing, and the -
H2AX foci in their bronchial epithelial cells were detected by immunohistochemistry of paraffin 
embedded sections.   
 
The foci were not uniformly distributed among the cell types in the lung.  More -H2AX foci 
formed in the epithelial cells of the conducting airways (comprising the bronchi and bronchioles) 
than in the respiratory airways (the alveoli).  Within the conducting airways more foci formed in 
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basal calls than in apical cells of the epithelium (Figure 1). As previously noted by Rübe and 
colleagues (13), there were also fewer foci formed in the stromal cell nuclei in the parenchyma 
of the lung in irradiated mice.  We counted foci in bronchial epithelial cells and found 
considerable differences between the strains (Figure 2).  Since the bronchial epithelial cells are 
identified histologically by their positions within the tissue, our computer algorithms (3-5) could 
not be used here and we had to rely on human counts. As we reviewed extensively in the past 
(6), manual foci counting can be affected by large inter-observer variability.  To account for this, 
foci were counted by two different individuals, both blinded to the lung cancer incidence in the 
different strains.   
 
Background levels of foci per nucleus in the bronchial epithelial cells of unirradiated mice (two 
mice assayed per strain) were low, about 3 for BALB/c and about 1.5 for the CcS strains.  The 
numbers of foci per nucleus were higher in irradiated mice (4 mice assayed per strain, with the 
exception of CcS/Dem13 for which only 3 mice were available), and differed considerably 
between strains (Table 2).   To determine if strains with less efficient repair were at greater risk 
for radiogenic lung cancer, we computed the Pearson’s correlation between average lung cancer 
incidence for each strain (9) with the average number of remaining RIF 24 hour post-exposure.  
Since the RIF data were from female mice, they were compared to lung cancer incidence in 
female mice only.  However, for some strains relatively few female mice were phenotyped for 
lung cancer susceptibility, so a comparison was also made to lung cancer incidence in both sexes 
combined.  The caveat with this approach is that for a number of other radiogenic tumors for 
which larger datasets are available, there are sex differences in incidence.  Strong correlations 
between persistent RIF levels measured in female mice and lung cancer incidence were found by 
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both observers (R2 = 60.56%, P < 0.001 for the incidence in female mice and R2 = 79.18%, P < 
0.001 for the incidence in both sexes) (Figure 3).  However, the RIF counts of observer 1 were 
more closely correlated with incidence than those of observer 2 (observer 1, R2 = 95.66%, P < 
0.001; observer 2, R2 = 68.52%, P < 0.001 for the correlations with incidence in both sexes). The 
inter-observer difference is likely due to the selection of cells in which to count foci.  
Interestingly, spontaneous levels of foci in non-irradiated strains also showed good correlation 
with lung cancer incidence in both sexes as measured by observer 1 (R2=32.74%, P =0.013 – 
Figure 3 C). 
 
To determine if strain differences in DNA DSB repair efficiencies in peripheral blood leukocytes 
also correlated with radiogenic lung cancer susceptibility, we undertook a more limited 
experiment in which we irradiated additional BALB/c mice and mice from 4 CcS/Dem strains 
that had high, low and intermediate repair efficiencies in their bronchial epithelial cells.  The foci 
were counted by observer 1 and the results are presented in Table 3.  Although the observer 
attempted to count foci only in lymphocytes based on nuclear morphology, monocytes could not 
be reliably excluded from the counts.  However, monocytes comprise only about 5% percent of 
murine peripheral blood leucocytes compared to about 80% for lymphocytes.  The foci counts 
correlated with lung cancer incidence in female mice (R2 = 86.354%, P = 0.022), though the 
correlation with lung cancer incidence in both sexes was not quite significant (R2 = 75.69%, P = 
0.055) (Figure 4).  The results indicate that the repair capacity in peripheral blood leucocytes is a 
good predictor of radiogenic lung cancer susceptibility in these strains. 
 
DISCUSSION 
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The link between cancer and deficient DNA repair has been extensively documented by others 
(7-10). For example, individuals suffering from the hereditary cancer-prone disease xeroderma 
pigmentosum (XP) were found to have defective DNA Single Stand Break repairs after exposing 
their cells to UV light (11). With respect to the H2AX assay used in this work, one can list 
several studies where the same assay was critical to identify individuals with repair defects such 
as patients with genetic diseases like ataxia telangiectasia (AT), Nijmegen breakage syndrome 
(NBS) (12), xeroderma pigmentosum (XP) (13), Fanconi anemia (FA) (14), and radiation 
sensitive severe combined immunodeficiency (RS-SCID) (15). The most well-known factor 
linking DNA repair to cancer is probably the mutation in breast cancer susceptibility proteins 
type 1 and 2 (BRCA1 and BRCA2) as these two genes are known to play a critical role in DNA 
DSB repair (16). Note that ATM defects that result in persistent RIF (4, 17) are associated with 
radiation-induced carcinogenesis in mice (18), and increased toxicity from radiotherapy in ATM 
heterozygous patients (19, 20). Finally, DNA repair deficiencies are considered risk factors for 
both acute radiation toxicity and cancer, independently of the type of radiation (21-25). The 
sizeable body of work linking DNA repair defects to cancer risks is beyond the scope of this 
work, but one can summarize it with this simple paradigm: defective DNA repair leads to 
genomic instability, which in turn lead to accumulated mutations and potentially cancer. We 
previously proposed mathematical formalism linking DNA repair deficiency to carcinogenesis 
and a more detail review of the literature on the topic can be found there as well (26).  
A major finding which emerges from this study is that most of the variance in 
susceptibility to radiogenic lung cancer in the CcS/Dem strains can be attributed to strain 
differences in DNA DSB repair efficiencies detectable by the LDR -H2AX assay.  The R2 for 
the combined foci counts of both observers in both sexes was 79%, suggesting 79% of the 
variance in lung cancer susceptibility is explained by differences in repair capacity.    Since the 
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mice that comprise the CcS/Dem strain set ultimately trace back to wild populations, an 
implication of this finding is that within these populations naturally occurring differences in 
DNA DSB repair efficiency might underlie interindividual differences in radiogenic lung cancer 
susceptibility.  Might this also be the case for humans?  We have reported differences in repair 
efficiencies in human fibroblasts from different normal donors detected by the LDR -H2AX 
assay, with about a 40% of those screened having relatively inefficient repair. The magnitudes of 
the strain or interindividual differences are comparable between mice and humans (the mean foci 
count in fibroblasts from 15 normal human donors ranged from 4.5 to 11.3 per nucleus; for 
bronchial epithelial cells in the 17 CcS/Dem strains assayed the range was 8.2 to 23.1 foci per 
nucleus) (10). Another finding worth noting is the 33% correlation between baseline γ-H2AX 
foci level in the bronchial epithelial cells from the 20 CcS/Dem strains and their reported cancer 
incidence. This correlation was found to be statistically significant and confirms the concept that 
baseline damage levels in an individual is the net balance between spontaneous damage being 
generated in the tissue and the efficiency of the repair machinery constantly clearing them (26). 
Higher foci level in an individual either reflect exposure to agents damaging DNA and/or slower 
repair. 
 
 
However, a couple of caveats need to be considered in extrapolating our findings to populations 
and to humans.  The first is, obviously, that there are likely to be differences between the 
pathogenesis of radiation-induced lung cancers in mice and humans, so further study will be 
necessary to link repair proficiency with radiogenic lung cancer in humans.  The second is in 
extrapolating the magnitude of an effect determined in a strain set to a general population.  There 
is limited genetic diversity in the CcS/Dem strains.  Since they derive from two inbred founder 
strains there can be at most two alleles for each locus.  So, while differences in susceptibility 
between BALB/c and CcS/Dem strains can be largely or entirely explained by their differing 
repair capacities, there may be other collections of inbred strains that differ in susceptibility due 
to other causes. By extension to humans, differences in DNA DSB repair efficiencies in a 
general population may explain only part of the variance in lung cancer susceptibility. 
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The finding that strain differences in repair efficiency measured in peripheral blood 
leucocytes mirrors those in bronchial epithelial cells and consequently correlate with radiogenic 
lung cancer is not surprising.  We demonstrated that the LDR -H2AX assay distinguished 
individuals with one defective copy of ATM from individuals with two defective copies or two 
normal copies, regardless of whether the assay employed fibroblasts or lymphoblasts (14).  This 
work also reflects that LDR -H2AX assay may be able to identify new genetic variance 
involved in DNA repair and potential cancer risk. A previous study had already suggested such 
findings with RIF repair kinetic assay being sensitive enough to detect subtle genetic differences 
in primary human fibroblast derived from 25 apparently healthy individuals and 10 patients with 
DNA repair-defective syndromes (27). In this work, authors showed clear kinetic differences 
with sick patients but even within the healthy donor, a wide variation in RIF levels and kinetics 
was observed suggesting other unknown factors influencing DNA repair. In mice, Rübe and 
colleagues (15) followed the kinetics of DNA DSB repair in two traditional laboratory mouse 
strains (BALB/c and C57BL/6), a strain engineered with a knockout allele of Atm, and a SCID 
strain with a spontaneous mutation in the gene encoding the catalytic subunit of DNA dependent 
protein kinase (Prkdc).  The latter two strains have profound defects in DNA DSB repair.  They 
observed that the rank order of repair efficiencies between the four strains of mice was the same 
regardless of the tissues assayed (lung, brain, heart or intestine irradiated in vivo and peripheral 
blood lymphocytes irradiated ex vivo). One way to compare directly human and mouse data is 
the usage of blood samples. For example in our study, the baseline level damage for figure 4 was 
XXX which is comparable to the reported 0.5 to 1 foci/cell in adult healthy donors PBL (28, 29).  
Unlike bronchial epithelial cells, peripheral blood cells are readily accessible; so, it should be 
possible to test for a correlation between repair efficiency of peripheral blood lymphocytes 
irradiated ex vivo and radiogenic cancer susceptibility in humans if a suitable cohort could be 
identified. 
 
SUPPLEMENTARY INFORMATION 
Detailed methods or tissue collection, immunofluorescent staining, and foci quantification are 
available as Supplementary Information. 
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Figure 1.  Section of irradiated lung showing many radiation-induced foci formed in the basal 
epithelial cells compared to the apical cells or stromal cells.  
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Figure 2.  Frequency histograms of the number of -H2AX foci per cell in lung basal epithelial 
cells in CcS/Dem strains and BALB/c mice. The more efficient the strain in DSB repair the more 
its histogram will be skewed to the left. 
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Figure 3.  Correlation between repair efficiencies and radiogenic lung cancer incidences in 
BALB/c and CcS/Dem strains.  Repair efficiencies are expressed as foci counts per nucleus in 
the LDR γ-H2AX assay.  To account for inter-observer variability, the foci counts for both 
observers are plotted (■ observer 1, ● observer 2) and the correlation of foci to incidence are 
calculated using all of the data points. 
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Figure 4.  Correlation between repair efficiencies in peripheral blood leucocytes and radiogenic 
lung cancer incidences in BALB/c and CcS/Dem strains, CcS2, CcS3, CcS4 and CcS10.   
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